Search Within

THYROID CANCER
Results 1 - 78 of 78
Carcinogenesis and Therapeutic Strategies in Thyroid Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 6
Page: 716-732
Authors: Zhi-Min Liu, Ting-Ting Wu, C. Andrew van Hasselt and George G. Chen

Regulation of Cell Growth by Estrogen Signaling and Potential Targets in Thyroid Cancer

Journal: Current Cancer Drug Targets
Volume: 8,Issue: 5
Page: 367-377
Authors: George G. Chen, Alexander C. Vlantis, Qiang Zeng and C. Andrew van Hasselt

Interlinking of Hypoxia and Estrogen in Thyroid Cancer Progression

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 11
Page: 1351-1360
Authors: S. Rajoria, E. Hanly, A. Nicolini, A.L. George, J. Geliebter, E.J. Shin, R. Suriano, A. Carpi and R.K. Tiwari

The Emerging Role of Sunitinib in the Treatment of Advanced Epithelial Thyroid Cancer: Our Experience and Review of Literature

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11,Issue: 9
Page: 746-752
Authors: G. Pasqualetti, S. Ricci, A. Dardano, M. Ferdeghini, M. Del Tacca and F. Monzani

Treatment of Patients with Advanced Thyroid Cancer

Journal: Current Biomarkers
Volume: 6,Issue: 1
Page: 10-25
Authors: Jose M. Gomez-Saez

AKT: A Potential Target for Thyroid Cancer Therapy

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 4,Issue: 3
Page: 181-185
Authors: Faiza Kada, Motoyasu Saji and Matthew D. Ringel

Telomeres and Thyroid Cancer

Journal: Current Genomics
Volume: 10,Issue: 8
Page: 526-533
Authors: Marco Capezzone, Stefania Marchisotta, Silvia Cantara and Furio Pacini

Diagnostic and Therapeutic Use of Human Recombinant Thyrotropin (rhTSH)(Thyrogen®) in Well-Differentiated Thyroid Cancer - Current Indications and Future Perspectives - A Review

Journal: Current Pharmaceutical Analysis
Volume: 6,Issue: 1
Page: 1-14
Authors: Joanna Klubo-Gwiezdzinska, Kenneth D. Burman, Douglas Van Nostrand and Leonard Wartofsky

Targeting the ERK Pathway: Novel Therapeutics for Thyroid Cancer

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 4,Issue: 3
Page: 199-220
Authors: Sandra F. Williams and Robert C. Smallridge

Targeting Angiogenesis in Thyroid Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 2
Page: 107-112
Authors: S. Lkhoyaali, S. Benhmida, M. Aitelhaj, M. Layachi, H. Abahssain, H.N. Ismaili and H. Errihani

Effects and Role of Multikinase Inhibitors in Thyroid Cancer

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 39
Page: 5915-5926
Authors: Rasmus Laursen, Markus Wehland, Sascha Kopp, Jessica Pietsch, Manfred Infanger, Jirka Grosse and Daniela Grimm

Silencing GPX3 Expression Promotes Tumor Metastasis in Human Thyroid Cancer

Journal: Current Protein & Peptide Science
Volume: 16,Issue: 4
Page: 316-321
Authors: Hua Zhao, Jingyi Li, Xin Li, Chao Han, Yi Zhang, Lili Zheng and Mingzhou Guo

New Targeted Therapies for Thyroid Cancer

Journal: Current Genomics
Volume: 12,Issue: 8
Page: 626-631
Authors: Alessandro Antonelli, Poupak Fallahi, Silvia M. Ferrari, Ilaria Ruffilli, Francesca Santini, Michele Minuto, David Galleri and Paolo Miccoli

18F-DOPA and 18F-FDG PET/CT, Scintigraphic Localization and Radioguided Surgery of Recurrent Medullary Thyroid Cancer: Two Case Reports

Journal: Current Radiopharmaceuticals
Volume: 7,Issue: 2
Page: 133-137
Authors: Laura Evangelista, Mohsen Farsad, Andrea Piotto and Maria R. Pelizzo

Synthesis and Anti-thyroid Cancer Effect of Iodo-chrysin Derivatives

Journal: Medicinal Chemistry
Volume: 12,Issue: 5
Page: 441-447
Authors: Yun Wei, Qutong Zheng, Guotao Tang, Chen Song, Guan Wang, Yinxiang Zhang, Yan Xiao, Xianliang Zeng, Zongbao Wang, Jichang Xiao and Xing Zheng

Redifferentiation Therapy in Advanced Thyroid Cancer

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 4,Issue: 3
Page: 175-180
Authors: Bryan R. Haugen

Telomerase as Drug and Drug Target for the Treatment of Thyroid Cancer

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 4,Issue: 3
Page: 253-256
Authors: M. A. Zeiger and A. K. Meeker

Treatment of Anaplastic Thyroid Cancer: Is there a Role for PPARγ Agonists?

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 2,Issue: 3
Page: 194-199
Authors: Alessandro Antonelli, Silvia M. Ferrari, Poupak Fallahi, Piero Berti, Gabriele Materazzi, Emiliano Ghiri, Angelo Carpi, Andrea Nicolini and Paolo Miccoli

Cabozantinib in Thyroid Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 10,Issue: 3
Page: 259-269
Authors: Poupak Fallahi, Silvia M. Ferrari, Flavia Di Bari, Gabriele Materazzi, Salvatore Benvenga, Paolo Miccoli and Alessandro Antonelli

Genetic Alterations in Differentiated Thyroid Cancers

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 9,Issue: 3
Page: 257-268
Authors: Behrouz Salehian, Zhong Liu and Fouad Kandeel

Treatment Directed to Signalling Molecules in Patients with Advanced Differentiated Thyroid Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 3
Page: 483-495
Authors: Jose M.G. Saez

Off-Label Use of Sunitinib in Patients with Advanced, Epithelial Thyroid Cancer: A Retrospective Analysis

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 6,Issue: 2
Page: 171-176
Authors: Giuseppe Pasqualetti, Sergio Ricci, Giuseppe Boni, Sara Tognini, Antonio Polini, Giuliano Mariani, Marco Ferdeghini and Fabio Monzani

Thyroid Cancer Incidence 25 Years After Chernobyl, in a Romanian Cancer Center: Is it a Public Health Problem?

Journal: Current Radiopharmaceuticals
Volume: 6,Issue: 4
Page: 249-252
Authors: Doina Piciu

Tumour Re-Differentiation Effect of Retinoic Acid: A Novel Therapeutic Approach for Advanced Thyroid Cancer

Journal: Current Pharmaceutical Design
Volume: 11,Issue: 19
Page: 2525-2531
Authors: Sabrina M. Coelho, Mario Vaisman and Denise P. Carvalho

Personalization of Targeted Therapy in Advanced Thyroid Cancer

Journal: Current Genomics
Volume: 15,Issue: 3
Page: 190-202
Authors: Poupak Fallahi, Silvia Martina Ferrari, Valeria Mazzi, Roberto Vita, Salvatore Benvenga and Alessandro Antonelli

Diagnostic and Prognostic Markers in Differentiated Thyroid Cancer

Journal: Current Genomics
Volume: 12,Issue: 8
Page: 597-608
Authors: Jose M. Gomez Saez

Medullary Thyroid Cancer: New Targeted Molecular Therapies

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 4,Issue: 1
Page: 10-14
Authors: Alessandro Antonelli, Silvia Martina Ferrari, Poupak Fallahi, Michele Minuto, Alda Corrado, Rossella Bruno and Paolo Miccoli

Application of Molecular Diagnostics to the Evaluation of the Surgical Approach to Thyroid Cancer

Journal: Current Genomics
Volume: 15,Issue: 3
Page: 184-189
Authors: Paolo Miccoli

Molecular Pathways Associated with Aggressiveness of Papillary Thyroid Cancer

Journal: Current Genomics
Volume: 15,Issue: 3
Page: 162-170
Authors: Salvatore Benvenga and Christian A. Koch

The IGF-I/IGF-I Receptor Pathway: Implications in the Pathophysiology of Thyroid Cancer

Journal: Current Medicinal Chemistry
Volume: 12,Issue: 24
Page: 2881-2891
Authors: A. Ciampolillo, C. De Tullio and F. Giorgino

New Targeted Therapies for Anaplastic Thyroid Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 1
Page: 87-93
Authors: Alessandro Antonelli, Poupak Fallahi, Salvatore Ulisse, Silvia Martina Ferrari, Michele Minuto, Giovanna Saraceno, Francesca Santini, Valeria Mazzi, Massimo D'Armiento and Paolo Miccoli

Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 86-93
Authors: Silvia Martina Ferrari, Concettina La Motta, Stefania Sartini, Enke Baldini, Gabriele Materazzi, Ugo Politti, Ilaria Ruffilli, Salvatore Ulisse, Paolo Miccoli, Alessandro Antonelli and Poupak Fallahi

Metastatic Thyroid Cancer Unresponsive to Conventional Therapies: Novel Management Approaches Through Translational Clinical Research

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 1,Issue: 2
Page: 103-115
Authors: N. J. Sarlis

Medullary Thyroid Cancer: A Promising Model for Targeted Therapy

Journal: Current Molecular Medicine
Volume: 10,Issue: 7
Page: 608-625
Authors: F. Torino, R. M. Paragliola, A. Barnabei and S. M. Corsello

Genetic Alterations in Medullary Thyroid Cancer: Diagnostic and Prognostic Markers

Journal: Current Genomics
Volume: 12,Issue: 8
Page: 618-625
Authors: A. Taccaliti, F. Silvetti, G. Palmonella and M. Boscaro

Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 7
Page: 636-649
Authors: Silvia Martina Ferrari, Gabriele Materazzi, Enke Baldini, Salvatore Ulisse, Paolo Miccoli, Alessandro Antonelli and Poupak Fallahi

Epigenetics in Medullary Thyroid Cancer: From Pathogenesis to Targeted Therapy

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 11,Issue: 3
Page: 275-282
Authors: Giovanni Vitale, Alessandra Dicitore, Erika Messina, Concetta Sciammarella, Antongiulio Faggiano and Annamaria Colao

Editorial (Thematic Issue: “Molecular Profiling and Ways Towards Personalized Medicine in Advanced Differentiated Thyroid Cancer”)

Journal: Current Genomics
Volume: 15,Issue: 3
Page: 161-161
Authors: Alessandro Antonelli

Editorial (Thematic Issue: Thyroid Cancer in Children and Adolescents)

Journal: Current Pediatric Reviews
Volume: 12,Issue: 4
Page: 246-246
Authors: Claudio Spinelli

Pediatric Differentiated Thyroid Cancer: When to Perform Conservative and Radical Surgery

Journal: Current Pediatric Reviews
Volume: 12,Issue: 4
Page: 247-252
Authors: Claudio Spinelli, Leonardo Rossi, Jessica Piscioneri, Silvia Strambi, Alessandro Antonelli, Andrea Ferrari, Maura Massimino and Paolo Miccoli

Radioiodine Treatment of Differentiated Thyroid Carcinoma: The Experience at Seoul National University Hospital

Journal: Current Medical Imaging Reviews
Volume: 6,Issue: 1
Page: 2-7
Authors: Ho Young Lee, June-Key Chung, Jong Jin Lee, So Won Oh, Keon Wook Kang, Do Joon Park, Bo Youn Cho and Myung Chul Lee

Viral Mediated Gene Therapy for the Management of Metastatic Thyroid Carcinoma

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 4,Issue: 3
Page: 235-244
Authors: Leslie J. DeGroot and Rusheng Zhang

Thyroglobulin Autoantibodies as Surrogate Biomarkers in the Management of Patients with Differentiated Thyroid Carcinoma

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 32
Page: 3687-3692
Authors: U. Feldt-Rasmussen, F.A. Verburg, M. Luster, C. Cupini, L. Chiovato, L. Duntas, R. Elisei, H. Rimmele, E. Seregni, J.W.A. Smit, C. Theimer and L. Giovanella

An Unusual Cause of Low Oxygen Saturation in the Operating Room

Journal: Current Respiratory Medicine Reviews
Volume: 2,Issue: 3
Page: 321-323
Authors: Joseph Varon, Pilar Acosta and Ross Reul

The Use of Radioactive Iodine in the Management of Hyperthyroidism in Children

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 1,Issue: 3
Page: 255-264
Authors: Scott A. Rivkees

Ectopic Thyroid Gland: Description of a Case and Review of the Literature

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 13,Issue: 3
Page: 275-281
Authors: Vincenzo Triggiani, Vito Angelo Giagulli, Brunella Licchelli, Francesco Resta, Giorgio Fiore, Giovanni De Pergola, Carlo Sabbà and Edoardo Guastamacchia

Molecular Diagnostics of Fine Needle Aspiration for the Presurgical Screening of Thyroid Nodules

Journal: Current Genomics
Volume: 15,Issue: 3
Page: 171-177
Authors: Poupak Fallahi, Riccardo Giannini, Paolo Miccoli, Alessandro Antonelli and Fulvio Basolo

The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications

Journal: Current Genomics
Volume: 18,Issue: 3
Page: 244-254
Authors: Ana Cunha Rodrigues, Gustavo Penna, Elisabete Rodrigues, Patrícia Castro, Manuel Sobrinho-Simoes and Paula Soares

Iodine-Refractory Thyroid Carcinoma

Journal: Reviews on Recent Clinical Trials
Volume: 1,Issue: 2
Page: 133-141
Authors: Apar K. Ganti and Ezra E.W. Cohen

Recent Advances of MEK Inhibitors and Their Clinical Progress

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 14
Page: 1364-1378
Authors: Wang John (Yuan), Wilcoxen M. Keith, Nomoto Kenichi and Wu Sara

BRAF Inhibitor Therapy for Melanoma, Thyroid and Colorectal Cancers: Development of Resistance and Future Prospects

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 2
Page: 128-143
Authors: Md Atiqur Rahman, Ali Salajegheh, Robert Anthony Smith and Alfred King-yin Lam

The Thyroid Gland: A Crossroad in Inflammation-Induced Carcinoma? An Ongoing Debate with New Therapeutic Potential.

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 30
Page: 3449-3461
Authors: A. Bozec, S. Lassalle, V. Hofman, M. Ilie, J. Santini and P. Hofman

Glucagon-Like Peptide-1 Receptor Agonists for Type 2 Diabetes: A Clinical Update of Safety and Efficacy

Journal: Current Diabetes Reviews
Volume: 12,Issue: 4
Page: 403-413
Authors: Scott R. Drab

Recent Advances in the Research and Development of B-Raf Inhibitors

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 16
Page: 1618-1634
Authors: Hui-Fang Li, Yadong Chen, Sha-Sha Rao, Xiu-Mei Chen, Hai-Chun Liu, Ji-Hong Qin, Wei-Fang Tang, Yue-Wang, Xiang Zhou and Tao Lu

Progress Towards Therapeutic Small Molecule MEK Inhibitors for Use in Cancer Therapy

Journal: Current Topics in Medicinal Chemistry
Volume: 5,Issue: 2
Page: 215-229
Authors: Eli M. Wallace, Joseph P. Lyssikatos, Tammie Yeh, James D. Winkler and Kevin Koch

Similar and Shared Nongenomic Mechanisms of Action of Estrogen and Thyroid Hormone

Journal: Immunology‚ Endocrine & Metabolic Agents in Medicinal Chemistry
Volume: 9,Issue: 2
Page: 84-89
Authors: Faith B. Davis, Hung-Yun Lin, Mary K. Luidens, Min Zhou and Shaker A. Mousa

Positron Emission Tomography Radiopharmaceuticals for Sex Steroid Hormone Receptor Imaging

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 20
Page: 3266-3270
Authors: Y. Kiyono, T. Mori and H. Okazawa

A Transporter Gene (Sodium Iodide Symporter) for Dual Purposes in Gene Therapy: Imaging and Therapy

Journal: Current Gene Therapy
Volume: 2,Issue: 4
Page: 393-402
Authors: Je-Yoel Cho

Nanotechnology and Radiopharmaceuticals: Diagnostic and Therapeutic Approaches

Journal: Current Drug Delivery
Volume: 7,Issue: 2
Page: 168-174
Authors: Maria Mironidou-Tzouveleki and Stergios Tsartsalis

Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas

Journal: Current Genomics
Volume: 12,Issue: 8
Page: 609-617
Authors: Paula Soares, Jorge Lima, Ana Preto, Patricia Castro, Joao Vinagre, Ricardo Celestino, Joana P. Couto, Hugo Prazeres, Catarina Eloy, Valdemar Maximo and M. Sobrinho-Simoes

Ovulation Inducing Agents and Cancer Risk: Review of Literature

Journal: Current Drug Safety
Volume: 6,Issue: 4
Page: 250-258
Authors: Gianna Gabriella Impicciatore and Gian Mario Tiboni

Induction of Thyroid Neoplasm Following Plant Medicine Marine Algae (Sargassum): A Rare Case and Review of the Literature

Journal: Current Pharmaceutical Biotechnology
Volume: 14,Issue: 9
Page: 859-863
Authors: George Zhu, Fabio Musumeci and Peter Byrne

A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 1
Page: 37-47
Authors: Subhajit Roy, Bawneet K. Narang, Shiva K. Rastogi and Ravindra K. Rawal

Papillary Thyroid Carcinoma in Pediatric Age: An Example of a Rare Tumour Managed Within a Cooperative Comprehensive Project

Journal: Current Pediatric Reviews
Volume: 12,Issue: 4
Page: 265-271
Authors: Giovanna Sironi, Andrea Ferrari, Marta Podda, Stefano Chiaravalli, Gianni Bisogno, Giovanni Cecchetto and Maura Massimino

Estrogen Catechols Detection as Biomarkers in Schistosomiasis Induced Cancer and Infertility

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 2
Page: 135-138
Authors: Monica C. Botelho, Helena Alves and Joachim Richter

Development of RET Kinase Inhibitors for Targeted Cancer Therapy

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 2
Page: 162-175
Authors: L. Mologni

Diagnostic Usefulness of Tumor Markers in the Thyroid Cytological Samples Extracted by Fine-Needle Aspiration Biopsy

Journal: Endocrine, Metabolic & Immune Disorders-Drug Targets
Volume: 10,Issue: 1
Page: 47-56
Authors: Jose Manuel Gomez Saez

Merlin, a “Magic” Linker Between the Extracellular Cues and Intracellular Signaling Pathways that Regulate Cell Motility, Proliferation, and Survival

Journal: Current Protein & Peptide Science
Volume: 11,Issue: 6
Page: 471-484
Authors: Ivan Stamenkovic and Qin Yu

The PAX8 / PPARγ Fusion Oncogene as a Potential Therapeutic Target in Follicular Thyroid Carcinoma

Journal: Current Drug Target - Immune, Endocrine & Metabolic Disorders
Volume: 4,Issue: 3
Page: 221-234
Authors: Bryan McIver, Stefan K.G. Grebe and Norman L. Eberhardt

Editorial: New Therapies, Markers and Therapeutic Targets in HCV Chronic Infection and HCV Extrahepatic Manifestations

Journal: Current Drug Targets
Volume: 18,Issue: 7
Page: 752-755
Authors: Alessandro Antonelli and Mauro Pistello

Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 2
Page: 202-213
Authors: R. Pignatello, D. Paolino, V. Panto, V. Pistara, M. G. Calvagno, D. Russo, G. Puglisi and M. Fresta

The Radionuclide Molecular Imaging and Therapy of Neuroendocrine Tumors

Journal: Current Cancer Drug Targets
Volume: 5,Issue: 2
Page: 139-148
Authors: Shuren Li and Mohsen Beheshti

Therapeutic Strategies for Targeting BRAF in Human Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 2
Page: 121-134
Authors: Christine A. Pratilas and David B. Solit

SPECT-CT in Radiotherapy Planning, with Main Reference to Patients with Breast Cancer

Journal: Current Radiopharmaceuticals
Volume: 8,Issue: 1
Page: 9-18
Authors: Sonya Sergieva, Iglika Mihaylova, Elena Alexandrova, Milena Dimcheva and Luigi Mansi

18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience

Journal: Current Radiopharmaceuticals
Volume: 9,Issue: 3
Page: 228-234
Authors: Francesco Bertagna, Domenico Albano, Giovanni Bosio, Arnoldo Piccardo, Bassam Dib and Raffaele Giubbini

PET Radiopharmaceuticals for Personalized Medicine

Journal: Current Drug Targets
Volume: 17,Issue: 16
Page: 1894-1907
Authors: Sushil Sharma

Experience with Indium-111 and Yttrium-90-Labeled Somatostatin Analogs

Journal: Current Pharmaceutical Design
Volume: 8,Issue: 20
Page: 1781-1807
Authors: I. Virgolini, T. Traub, C. Novotny, M. Leimer, B. Fuger, S. R. Li, P. Patri, T. Pangerl, P. Angelberger, M. Raderer, G. Burggasser, F. Andreae, A. Kurtaran and R. Dudczak

Editorial Review of 2014

Journal: Current Radiopharmaceuticals
Volume: 7,Issue: 1
Page: 1-4
Authors: Sean L. Kitson and Luigi Mansi

Results 1 - 78 of 78